Invitrotek ltd. Sti. (Istanbul, turkey) and pronto diagnostics ltd. (Tel aviv, israel) will collaborate in developing an assay, based on the targeted next generation sequencing to detect mutations in all thalassemia cases.
The oral cavity is a unique organ and an entry gate to the whole body. The oralgerd project aims at developing a generic electronic intra-oral technological platform attached to a tooth for various applications such as gerd diagnostics, drug delivery, body health monitoring, and more.
Development of rapamycin eluting stents based on crystallization of the drug onto stent surface aims to develop a crystalline carrier-free coating of rapamycin onto stents which will keep the original metallic stent in the body after the drug has been released
The need of growth systems capable of growing cells in physiological 3d culture for therapeutic applications is rapidly increasing. The purpose is the development of novel technology that will allow the growth of 3d cells & tissue cultures in disposable controlled bioreactors system.